Dr Chinedu Nwasike, MD | |
7455 W Washington Ave Ste 160, Las Vegas, NV 89128-4356 | |
(702) 878-0393 | |
(702) 258-3777 |
Full Name | Dr Chinedu Nwasike |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 10 Years |
Location | 7455 W Washington Ave Ste 160, Las Vegas, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811302102 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Mountainview Hospital | Las vegas, NV | Hospital |
Southern Hills Hospital And Medical Center | Las vegas, NV | Hospital |
Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nevada Orthopedic And Spine Center | 4284622895 | 25 |
News Archive
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.
In a guest column for the New Jersey Star-Ledger, a former White House spokesman and Chief-of-Staff for the House Aging Committee and Health Subcommittee, Robert Weiner, a George Washington University breast cancer laboratory director and professor, Dr. Patricia Berg, and policy analyst, James Lewis assert that "as the government keeps funding two wars and ongoing tax breaks, curing diseases like cancer is being threatened in the budget debates underway.
MinuteClinic medical clinics in select CVS/pharmacy stores throughout Maryland, North Carolina and Tennessee are now offering H1N1 vaccinations on demand seven days a week with no appointment necessary.
Caraco Pharmaceutical Laboratories, Ltd. generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for the corresponding periods of our previous fiscal year ended December 31, 2009.
Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.
› Verified 5 days ago
Entity Name | Nevada Orthopedic & Spine Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437158771 PECOS PAC ID: 4284622895 Enrollment ID: O20040517000283 |
News Archive
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.
In a guest column for the New Jersey Star-Ledger, a former White House spokesman and Chief-of-Staff for the House Aging Committee and Health Subcommittee, Robert Weiner, a George Washington University breast cancer laboratory director and professor, Dr. Patricia Berg, and policy analyst, James Lewis assert that "as the government keeps funding two wars and ongoing tax breaks, curing diseases like cancer is being threatened in the budget debates underway.
MinuteClinic medical clinics in select CVS/pharmacy stores throughout Maryland, North Carolina and Tennessee are now offering H1N1 vaccinations on demand seven days a week with no appointment necessary.
Caraco Pharmaceutical Laboratories, Ltd. generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for the corresponding periods of our previous fiscal year ended December 31, 2009.
Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Chinedu Nwasike, MD 7455 W Washington Ave Ste 160, Las Vegas, NV 89128-4356 Ph: (702) 878-0393 | Dr Chinedu Nwasike, MD 7455 W Washington Ave Ste 160, Las Vegas, NV 89128-4356 Ph: (702) 878-0393 |
News Archive
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.
In a guest column for the New Jersey Star-Ledger, a former White House spokesman and Chief-of-Staff for the House Aging Committee and Health Subcommittee, Robert Weiner, a George Washington University breast cancer laboratory director and professor, Dr. Patricia Berg, and policy analyst, James Lewis assert that "as the government keeps funding two wars and ongoing tax breaks, curing diseases like cancer is being threatened in the budget debates underway.
MinuteClinic medical clinics in select CVS/pharmacy stores throughout Maryland, North Carolina and Tennessee are now offering H1N1 vaccinations on demand seven days a week with no appointment necessary.
Caraco Pharmaceutical Laboratories, Ltd. generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for the corresponding periods of our previous fiscal year ended December 31, 2009.
Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.
› Verified 5 days ago
William Ralston Mcgee Ii, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9159 W Flamingo Rd Ste 100, Las Vegas, NV 89147 Phone: 024-855-8857 Fax: 888-593-7092 | |
Erik Noble Kubiak, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2231 West Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2663 Fax: 702-383-2682 | |
Dr. Victor Hoang, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-8436 | |
Dr. Edward Ratcliffe Anderson Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4750 W Oakey Blvd Ste 2b, Las Vegas, NV 89102 Phone: 702-579-3297 Fax: 702-796-2302 | |
Bradley Scott Baker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave, #160, Las Vegas, NV 89128 Phone: 702-878-0393 Fax: 702-933-0637 | |
Hugh S Selznick, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3006 S Maryland Pkwy, 570, Las Vegas, NV 89109 Phone: 702-777-2663 Fax: 702-777-0030 | |
Ronald W. Hillock, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave, #160, Las Vegas, NV 89128 Phone: 702-878-0393 Fax: 702-258-5564 |